• Jobs Slashed in Sanofi (France) (SAN.PA) Plant Closure More...
• Eleven Biotherapeutics Rakes in $20 Million Fundraise More...
• Sutro Biopharma Pulls in $16 Million for New Antibody Drugs More...
• Santen Pharmaceutical Nabs Japanese Co-Promotion Rights to Bayer HealthCare (BAY) and Regeneron Pharmaceuticals, Inc. (REGN)'s Eylea More...
• Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Announces Worldwide Exclusive Licensing Agreement With Monsanto Company (MON) More...
• Pressure BioSciences, Inc. (BBII) and LEAP Technologies, Inc. Announce Co-Development, Co-Marketing, & Co-Selling Agreement More...
• Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic More...
• Pozen, Inc. (POZN) Announces Licensing Deal with Desitin Pharmaceuticals GmbH for MT 400 Migraine Treatment in 29 European Countries More...
• Johnson & Johnson (JNJ) Chairman Weldon's Salary Cut to $1 Million After Stepping Down as CEO More...
• ZIOPHARM Oncology, Inc. (ZIOP.OB) Appoints Jason A. Amello as Executive Vice President and Chief Financial Officer More...
• Bio-Matrix Scientific Group Inc. (BMSN.OB) Hires President for Its Regen BioPharma Subsidiary More...
• Ruga Corporation Expands Management Team to Advance Its Adapative Response Therapeutics for Cancer Patients More...
• Oncology Expert George Demetri, M.D., Joins Blueprint Medicines as a Clinical Advisor More...
• Apricus Biosciences (APRI) Announces First Quarter 2012 Financial Results Conference Call and Provides Corporate Update More...
• Affymax, Inc. (AFFY) Reports First Quarter 2012 Financial Results More...
• Aastrom Biosciences, Inc. (ASTM) to Host First Quarter 2012 Investor Call on May 10, 2012 More...
• Antares Pharma, Inc. (AIS) Reports First Quarter 2012 Financial and Operating Results More...
• Akorn, Inc. (AKN) Reports Record First Quarter 2012 Financial Results More...
• Sanofi (France) (SAN.PA) Chemist is Jailed for Stealing Trade Secrets More...
• Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement With Abbott Laboratories (ABT) Over Off-Label Marketing of Antiepileptic Medication Depakote More...
• Celgene Corporation (CELG)'s Revlimid Linked to Certain New Cancers More...
• FDA Staff: Gilead Sciences, Inc. (GILD)'s Truvada May Help Prevent HIV Infection More...
• Novartis AG (NVS): Pasireotide Works Well in Phase III Acromegaly Trial More...
• Genta Incorporated (GETA.OB) Initiates Randomized Trial of Tesetaxel in Gastric Cancer More...
• Eleven Biotherapeutics Presents Data on EBI-005, a Novel IL-1 Inhibitor Protein for Topical Treatment of Dry Eye Disease More...
• Clinigen Gains FDA Approval for Foscavir in HIV/AIDS-related Cytomegalovirus Infections and Herpes More...
• Talon Therapeutics, Inc. (TLON.OB) Receives Notification of Three Month PDUFA Date Extension for Marqibo® More...
• GTx, Inc. (GTXI) Announces Removal of Full Clinical Hold by FDA for Capesaris® in Advanced Prostate Cancer More...
• Eating Fast Ups Diabetes Risk, Lithuanian University of Health SciencesStudy More...
• For Heart Attack Survivors, Living Near Roadways Linked with Death, Beth Israel Deaconess Medical Center Study More...
• Depression in Mid-Life Linked to Higher Odds for Later Dementia, University of California, San Francisco (UCSF) Study More...
• Men's Breast Cancer Often More Deadly, American Society of Breast Surgeons Reveals More...
• Exercise Slows Muscle Wasting from Age and Heart Failure, Martin Luther-University Halle-Wittenberg Study More...
• Eleven Biotherapeutics Rakes in $20 Million Fundraise More...
• Sutro Biopharma Pulls in $16 Million for New Antibody Drugs More...
• Santen Pharmaceutical Nabs Japanese Co-Promotion Rights to Bayer HealthCare (BAY) and Regeneron Pharmaceuticals, Inc. (REGN)'s Eylea More...
• Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Announces Worldwide Exclusive Licensing Agreement With Monsanto Company (MON) More...
• Pressure BioSciences, Inc. (BBII) and LEAP Technologies, Inc. Announce Co-Development, Co-Marketing, & Co-Selling Agreement More...
• Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic More...
• Pozen, Inc. (POZN) Announces Licensing Deal with Desitin Pharmaceuticals GmbH for MT 400 Migraine Treatment in 29 European Countries More...
• Johnson & Johnson (JNJ) Chairman Weldon's Salary Cut to $1 Million After Stepping Down as CEO More...
• ZIOPHARM Oncology, Inc. (ZIOP.OB) Appoints Jason A. Amello as Executive Vice President and Chief Financial Officer More...
• Bio-Matrix Scientific Group Inc. (BMSN.OB) Hires President for Its Regen BioPharma Subsidiary More...
• Ruga Corporation Expands Management Team to Advance Its Adapative Response Therapeutics for Cancer Patients More...
• Oncology Expert George Demetri, M.D., Joins Blueprint Medicines as a Clinical Advisor More...
• Apricus Biosciences (APRI) Announces First Quarter 2012 Financial Results Conference Call and Provides Corporate Update More...
• Affymax, Inc. (AFFY) Reports First Quarter 2012 Financial Results More...
• Aastrom Biosciences, Inc. (ASTM) to Host First Quarter 2012 Investor Call on May 10, 2012 More...
• Antares Pharma, Inc. (AIS) Reports First Quarter 2012 Financial and Operating Results More...
• Akorn, Inc. (AKN) Reports Record First Quarter 2012 Financial Results More...
• Sanofi (France) (SAN.PA) Chemist is Jailed for Stealing Trade Secrets More...
• Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement With Abbott Laboratories (ABT) Over Off-Label Marketing of Antiepileptic Medication Depakote More...
• Celgene Corporation (CELG)'s Revlimid Linked to Certain New Cancers More...
• FDA Staff: Gilead Sciences, Inc. (GILD)'s Truvada May Help Prevent HIV Infection More...
• Novartis AG (NVS): Pasireotide Works Well in Phase III Acromegaly Trial More...
• Genta Incorporated (GETA.OB) Initiates Randomized Trial of Tesetaxel in Gastric Cancer More...
• Eleven Biotherapeutics Presents Data on EBI-005, a Novel IL-1 Inhibitor Protein for Topical Treatment of Dry Eye Disease More...
• Clinigen Gains FDA Approval for Foscavir in HIV/AIDS-related Cytomegalovirus Infections and Herpes More...
• Talon Therapeutics, Inc. (TLON.OB) Receives Notification of Three Month PDUFA Date Extension for Marqibo® More...
• GTx, Inc. (GTXI) Announces Removal of Full Clinical Hold by FDA for Capesaris® in Advanced Prostate Cancer More...
• Eating Fast Ups Diabetes Risk, Lithuanian University of Health SciencesStudy More...
• For Heart Attack Survivors, Living Near Roadways Linked with Death, Beth Israel Deaconess Medical Center Study More...
• Depression in Mid-Life Linked to Higher Odds for Later Dementia, University of California, San Francisco (UCSF) Study More...
• Men's Breast Cancer Often More Deadly, American Society of Breast Surgeons Reveals More...
• Exercise Slows Muscle Wasting from Age and Heart Failure, Martin Luther-University Halle-Wittenberg Study More...
0 comments